Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are classified into the following four histopathologic subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. However, the clinicopathologic characteristics of IPMN subtypes have not been fully clarified. Recently, a subgroup classification of minimally invasive intraductal papillary mucinous carcinomas (MI-IPMCs) was suggested in contrast to overt invasive carcinoma from IPMCs (IC-IPMCs). The purpose of this study was to determine whether or not the pathologic subtype classification can predict prognosis and to validate the usefulness of the newly proposed diagnostic criteria of MI-IPMCs. We reviewed the clinicopathologic characteristics of 142 surgically resected cases of IPMNs. There were 54, 56, 30, and two cases of the gastric, intestinal, pancreatobiliary, and oncocytic types of IPMNs, respectively. The intestinal and pancreatobiliary types were more likely to have a main duct type. All gastric type tumors were adenomas or moderate dysplasia, whereas greater than one half of the intestinal and pancreatobiliary types were carcinomas in situ or invasive carcinomas. A significant difference in recurrence and death rate was noted for invasive carcinoma between the intestinal and pancreatobiliary types. The majority of MI-IPMCs were the intestinal type, whereas the majority of IC-IPMCs were the pancreatobiliary type. The IC-IPMC group showed a decreased recurrence-free and overall survival with statistically significance (p < 0.001 and p = 0.001, respectively). Our results suggest that the pathologic subtype classification and the newly proposed diagnostic criteria for minimal invasion may also be useful to predict prognosis of IPMNs of the pancreas.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-010-0148-zDOI Listing

Publication Analysis

Top Keywords

intestinal pancreatobiliary
20
intraductal papillary
12
papillary mucinous
12
pancreatobiliary types
12
minimal invasion
8
mucinous neoplasms
8
ipmns pancreas
8
gastric intestinal
8
pancreatobiliary oncocytic
8
clinicopathologic characteristics
8

Similar Publications

Article Synopsis
  • - The study addresses the limitations of using undefined basement membrane extracts like Matrigel for cultivating intestinal stem cells (ISCs) by introducing a new xenogeneic-free culture dish called XF-DISC.
  • - XF-DISC significantly increases the growth and maintenance of ISCs, achieving a 24-fold cell number increase within 30 days and sustaining viability over 210 days (30 passages).
  • - This method allows for successful transplantation of cultured human ISCs into mouse models with intestinal injuries, fostering tissue regeneration, making it a promising approach for effective ISC therapy in human intestinal diseases.
View Article and Find Full Text PDF

A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort.

ESMO Open

December 2024

Institut du Cancer Paris CARPEM, APHP, Hepatogastroenterology and GI Oncology Department, APHP Centre-Université Paris Cité, Hôpital Européen G. Pompidou, Paris, France. Electronic address:

Background: Ampullary carcinoma (AC) is a rare and severe gastrointestinal cancer with a disease recurrence rate of around 40% after curative-intent surgery and for which the main prognostic factors and adjuvant treatment decision remain a matter of debate.

Patients And Methods: The FFCD-AC cohort is a French nationwide prospective cohort, which included patients with non-metastatic resected AC. The primary objective of this study was to describe prognostic factors associated with disease-free survival (DFS) and overall survival (OS) after pancreaticoduodenectomy (PD) so as to propose a user-friendly score to better estimate the risk of recurrence.

View Article and Find Full Text PDF

Background: The information on the clinicopathologic/outcome differences between ampullary adenocarcinoma (AC) and pancreatic adenocarcinoma (PC) has been conflicting to the extent that it still is questioned whether ACs need to be recognized separately from PCs.

Methods: The characteristics of 413 ACs were compared with those of 547 PCs.

Results: The ACs had a better prognosis than the PCs (5-year survival, 57 % vs 23 %; p < 0.

View Article and Find Full Text PDF
Article Synopsis
  • The ampulla of Vater is a critical site in the duodenal wall where pancreatic and biliary ducts meet, often linked to tumors known as ampullary adenocarcinomas.
  • A study analyzed 188 cases to compare intra-ampullary and periampullary carcinomas in terms of pathology and survival, revealing that most tumors were found in males around 55 years old, with a predilection for the pancreatobiliary subtype.
  • Results indicated that intra-ampullary carcinomas had worse outcomes, showing more extensive invasion and lower median survival rates (46 months) compared to periampullary carcinomas (53.5 months).
View Article and Find Full Text PDF
Article Synopsis
  • Ampullary adenocarcinoma (AA) shows clinical and genetic diversity, and a new genomic classifier may improve patient classification beyond traditional methods, but it needs validation before being widely used.
  • A study involving 192 patients with AA assessed the accuracy of this genomic classifier against standard histology to see if it could predict survival outcomes.
  • Results indicated a 55% agreement between genomic and histological classifications; however, while histological subtypes did not predict survival, the genomic scores did correlate with survival probabilities, suggesting the genomic approach might be more effective.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!